@storm787878: FLM Hakone Japan - Dr Francis Leo Marcos PhD Humanitarian Pandemic Hero Philanthropist Panginoon ng Isabela Bogus Norman Mangusin Kulaong Budol #ofw #scammer #foryou

Storm
Storm
Open In TikTok:
Region: PH
Monday 07 September 2026 08:16:41 GMT
7372
55
9
1

Music

Download

Comments

anecito.codera
Anecito Codera :
ohhh! you see im a scammer!
2026-09-07 20:45:41
0
suprisedsydney
￴ ￴ ￴ ￴ ￴ ￴ ￴ ￴ ￴ ￴￴ ￴￴ ￴ :
napaka gwapo talaga ng isang FLM aba
2026-09-07 12:05:18
1
jundapogs
Jun Dapogs :
Tagsytatlng yan
2026-09-07 09:34:41
1
01kamadonezuko
Kamado nezuko :
idol baka mapa daan jan c onoda saka c manami
2026-09-07 09:54:14
1
tabudlo50
Pau :
hakuna matata
2026-09-07 09:31:35
1
reese_naturevlogs
🌴human_nature PH🇵🇭🌴 :
maubos na ang pera wag LNG ang yabang🤣
2026-09-07 18:10:16
0
rainomujedlll
Rain dejumo lll :
😁😁😁
2026-09-07 12:27:56
1
mr..t34
Mr. T :
🤣🤣🤣
2026-09-07 16:32:16
0
To see more videos from user @storm787878, please go to the Tikwm homepage.

Other Videos

Tap @OPZELURA® (ruxolitinib) PI for Med Guide, Boxed Warning, and Full PI info Eczema relief without steroids? That’s a reason to dance 💃🕺 INDICATION & USAGE OPZELURA is a prescription medicine used on the skin (topical) for the short-term and non-continuous chronic treatment of mild to moderate eczema in non-immunocompromised adults and children 2 years of age and older whose disease is not well controlled with topical prescription therapies or when those therapies are not recommended. The use of OPZELURA along with therapeutic biologics, other JAK inhibitors, or strong immunosuppressants such as azathioprine or cyclosporine is not recommended. It is not known if OPZELURA is safe and effective in children less than 2 years of age with atopic dermatitis. SELECT SAFETY INFORMATION OPZELURA may cause serious side effects, including: Serious Infections: OPZELURA is in a class of medicines called Janus kinase (JAK) inhibitors. JAK inhibitors can lower your ability to fight infections. Serious infections, some fatal, occurred when taking JAK inhibitors by mouth including tuberculosis and infections caused by bacteria, fungi, or viruses. Some lung infections were seen in people using OPZELURA. Before starting OPZELURA, tell your healthcare provider if you: have an infection (ie fever, sweating, chills), have diabetes, lung disease, HIV, or a weak immune system. Increased risk of death in people age 50+ with at least one heart disease risk factor when taking JAK inhibitors by mouth. Cancer and immune system problems: OPZELURA may increase your risk of certain cancers (lymphoma, lung, and skin) by changing the way your immune system works. Tell your doctor if you have had any type of cancer. Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least one heart disease risk factor when taking JAK inhibitors by mouth, especially in current or past smokers. Blood clots: Blood clots in veins of your legs (deep vein thrombosis) or lungs (pulmonary embolism) can happen. This may be life-threatening. These types of blood clots occurred more often in people 50+ with at least one heart disease risk factor when taking JAK inhibitors by mouth. Tap handle for full safety and Med Guide
Tap @OPZELURA® (ruxolitinib) PI for Med Guide, Boxed Warning, and Full PI info Eczema relief without steroids? That’s a reason to dance 💃🕺 INDICATION & USAGE OPZELURA is a prescription medicine used on the skin (topical) for the short-term and non-continuous chronic treatment of mild to moderate eczema in non-immunocompromised adults and children 2 years of age and older whose disease is not well controlled with topical prescription therapies or when those therapies are not recommended. The use of OPZELURA along with therapeutic biologics, other JAK inhibitors, or strong immunosuppressants such as azathioprine or cyclosporine is not recommended. It is not known if OPZELURA is safe and effective in children less than 2 years of age with atopic dermatitis. SELECT SAFETY INFORMATION OPZELURA may cause serious side effects, including: Serious Infections: OPZELURA is in a class of medicines called Janus kinase (JAK) inhibitors. JAK inhibitors can lower your ability to fight infections. Serious infections, some fatal, occurred when taking JAK inhibitors by mouth including tuberculosis and infections caused by bacteria, fungi, or viruses. Some lung infections were seen in people using OPZELURA. Before starting OPZELURA, tell your healthcare provider if you: have an infection (ie fever, sweating, chills), have diabetes, lung disease, HIV, or a weak immune system. Increased risk of death in people age 50+ with at least one heart disease risk factor when taking JAK inhibitors by mouth. Cancer and immune system problems: OPZELURA may increase your risk of certain cancers (lymphoma, lung, and skin) by changing the way your immune system works. Tell your doctor if you have had any type of cancer. Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least one heart disease risk factor when taking JAK inhibitors by mouth, especially in current or past smokers. Blood clots: Blood clots in veins of your legs (deep vein thrombosis) or lungs (pulmonary embolism) can happen. This may be life-threatening. These types of blood clots occurred more often in people 50+ with at least one heart disease risk factor when taking JAK inhibitors by mouth. Tap handle for full safety and Med Guide

About